SBIR/STTR Research Award

CO-AMPLIFIED RNAS FOR COMPARITIVE MICROARRAY ANALYSIS

Award identifier 35e723dbf2803d2a2058dfd1c2292309c9d0461d1f85c0c4ba62b16ba85a4136Awarding agency Department of Health and Human Services · National Institutes of Health

Award amount

$120,930

Program and phase

SBIR · Phase I

Award year

2002

Explore This Research Award in CaptureIQ

Research the technology, evaluate the recipient and agency, identify related opportunities, and explore potential follow-on work with CaptureIQ.

Award details

Awarding agency
Department of Health and Human Services
Branch
National Institutes of Health
Recipient company
AMBION DIAGNOSTICS, INC.
Proposal award date
Not reported
Contract end date
Not reported
UEI
Not reported
Solicitation number
Not reported
Topic code
Not reported

Research abstract

Ambion, Inc. proposes to develop methods and reagents that will make it possible to compare the expression profiles of small RNA samples (<1 microgram of RNA) using microarray analysis. The key element of the proposal is an amplification scheme that will allow two RNA populations to be co-verse transcribed and co-amplified in a single tube using the same reagents. Simultaneous amplification will obviate the effects of tube-to-tube variation that plagues current amplification schemes. Following amplification, sequences derived from the two input RNA samples will be labeled with different fluorescent dyes and the two target populations will be hybridized to a single microarray. In addition to a method for RNA amplification, Ambion proposes to improve the sensitivity of microarrays by developing an enhanced microarray hybridization solution by systematically assessing the benefits of known hybridization enhancers. Finally, an RNA reference population will be developed that will provide a standard against which data from many different experiments can be compared. PROPOSED COMMERCIAL APPLICATIONS: The proposed research has many commercial applications. Success in Phase I will result in an enhanced microarray hybridization system and internal control problems that will be useful for all microarray expression research. Phase II success will result in an amplification system that can be applied by individual researchers using limited RNA samples. Ambion will use the amplification scheme to provide nucleic acids from difficult to obtain samples to the research community.

Technology keywords

Not reported

Agency intelligence

Department of Health and Human Services

Back to SBIR/STTR Research Awards

Don't take our word for it. Ask AI about RFPCapture.

See what leading AI assistants have to say about RFPCapture and CaptureIQ.

Gemini opens without a prefilled question. The question is copied to your clipboard when the button works. You can also copy it here:

What is RFPCapture.com and its CaptureIQ platform from Smart Logic AI? How does it help federal contractors discover opportunities, evaluate bid/no-bid decisions, research government contracts, and prepare proposals? How does it compare with other federal capture platforms? Use independent sources where available.